ARCHIVE

• Femara for Breast Cancer: Novartis
  February 6, 2006

• JSMI to Submit Petition on Self-medication to Korosho
  February 6, 2006

• 3 Drugs, 1 Diagnostic Recommended for Approval
  February 6, 2006

• Group of Pharmacy Chains Calls For Sale of Drugs via Internet
  February 6, 2006

• Toyama, Nidek Granted Approval for Tosufloxacin Eye Drops
  February 6, 2006

• Sysmex to Shift Focus to Disease Management
  February 6, 2006

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  February 6, 2006

• Serono Japan Granted Approval for Follitropin a to Treat MHH
  February 6, 2006

• Eisai to Establish European Strategic Hub in the UK
  February 6, 2006

• Lead Chemical, Sankyo Announce Approval of Loxonin Poultice
  February 6, 2006

• Takeda's Future Depends on Its Drug Discovery Research: Mr Takeda
  February 6, 2006

• Obsessive Compulsive Disorders Approved as New Indication for Paxil: GSK
  February 6, 2006

• Toyama to Give Domestic Marketing Rights for T-3811 to Astellas
  February 6, 2006

• Contraindication of Paxil Lifted
  February 6, 2006

• Meiji Seika to Establish Specialist MRs for GE Drug Business
  February 6, 2006

• Study Group Approves 2nd Report on IRBs
  February 6, 2006

• Sumitomo, Summit Medi-Chem to Invest in Medisa Shinyaku: Sawai
  February 6, 2006

• Korosho Notifies Prefectures on How to Purchase, Stock Tamiflu
  February 6, 2006

• BUSINESS NEWS IN BRIEF
  February 6, 2006

• REGULATORY NEWS IN BRIEF
  February 6, 2006

ページ

• « 先頭
• ‹ Prev
• …
• 424
• 425
• 426
• 427
• 428
• 429
• 430
• 431
• 432
• …
• Next ›
• 最終 »